Skip directly to content

Development of Targeting Drugs

Dr. Jeffrey Tyner gives us a summary of efforts to apply gene-targeted therapies for cancer on an individualized basis. This touches on the basic biology of cancer as well as the technological revolution that is unfolding in the realm of DNA sequencing. Tyner is Assistant Professor in the Department of Cell & Developmental Biology at OHSU. His research focuses on identifying cancer-causing genes and on patient-tailored, gene-targeted, therapies.

Presenter : 
Dr. Jeffrey Tyner
Date: 
Sunday, May 11, 2014
EmbedCode: